Posted by Michael Wonder on 29 Nov 2020
Key PBS listing to save Australians with severe back and neck pain more than 20,000 dollars
29 November 2020 - Thousands of Australians with debilitating back and joint pain will have access to a life changing treatment option through the PBS which would otherwise cost tens of thousands of dollars.
From December 1, access to Taltz (ixekizumab) on the PBS will be expanded for patients with active ankylosing spondylitis.
Access to Xarelto (rivaroxaban) will be expanded to include the treatment of patients at high risk of recurrent cardiovascular events with coronary artery disease or peripheral artery disease.
